| scholarly article | Q13442814 |
| P50 | author | Amos Tanay | Q89144507 |
| Kira Orlovsky | Q123125880 | ||
| P2093 | author name string | Joseph Lotem | |
| Niv Pencovich | |||
| Yoram Groner | |||
| Dalia Goldenberg | |||
| Dena Leshkowitz | |||
| Dan Friedman | |||
| Oren Ben-Ami | |||
| P2860 | cites work | Relative expression software tool (REST©) for group-wise comparison and statistical analysis of relative expression results in real-time PCR | Q29400573 |
| P433 | issue | 6 | |
| P921 | main subject | leukemia | Q29496 |
| acute myeloid leukemia | Q264118 | ||
| P304 | page(s) | 1131-1143 | |
| P577 | publication date | 2013-09-19 | |
| P1433 | published in | Cell Reports | Q5058165 |
| P1476 | title | Addiction of t(8;21) and inv(16) acute myeloid leukemia to native RUNX1. | |
| P478 | volume | 4 |
| Q38738895 | A minicircuitry of microRNA-9-1 and RUNX1-RUNX1T1 contributes to leukemogenesis in t(8;21) acute myeloid leukemia |
| Q47284616 | A tool compound targeting the core binding factor Runt domain to disrupt binding to CBFβ in leukemic cells |
| Q47298164 | AML1/ETO trans-activates c-KIT expression through the long range interaction between promoter and intronic enhancer |
| Q40521783 | Addiction to RUNX in lymphoma |
| Q40723774 | Addiction to Runx1 is partially attenuated by loss of p53 in the Eµ-Myc lymphoma model |
| Q92627051 | An update on the molecular pathogenesis and potential therapeutic targeting of AML with t(8;21)(q22;q22.1);RUNX1-RUNX1T1 |
| Q41619527 | Applications of flow cytometry for measurement of autophagy. |
| Q38890974 | Applications of imaging flow cytometry in the diagnostic assessment of acute leukaemia |
| Q38690842 | Augmented expression of RUNX1 deregulates the global gene expression of U87 glioblastoma multiforme cells and inhibits tumor growth in mice |
| Q37183604 | Aurora kinase-induced phosphorylation excludes transcription factor RUNX from the chromatin to facilitate proper mitotic progression |
| Q47134182 | Autonomous feedback loop of RUNX1-p53-CBFB in acute myeloid leukemia cells |
| Q39442731 | C/EBPα deregulation as a paradigm for leukemogenesis |
| Q87757676 | C/EBPα overrides epigenetic reprogramming by oncogenic transcription factors in acute myeloid leukemia |
| Q89634514 | Complex Interplay between the RUNX Transcription Factors and Wnt/β-Catenin Pathway in Cancer: A Tango in the Night |
| Q91816459 | Core Binding Factor Leukemia: Chromatin Remodeling Moves Towards Oncogenic Transcription |
| Q38238954 | DNA damage accumulation and repair defects in acute myeloid leukemia: implications for pathogenesis, disease progression, and chemotherapy resistance |
| Q42602670 | Developmental-stage-dependent transcriptional response to leukaemic oncogene expression. |
| Q55355645 | Expression levels of the runt-related transcription factor 1 and 3 genes in the development of acute myeloid leukemia. |
| Q38858207 | Gene Silencing by RNAi in Mammalian Cells |
| Q41661754 | Genetic regulation of the RUNX transcription factor family has antitumor effects |
| Q35944651 | Genome Wide Mapping of NR4A Binding Reveals Cooperativity with ETS Factors to Promote Epigenetic Activation of Distal Enhancers in Acute Myeloid Leukemia Cells |
| Q55263355 | Glucocorticoids Inhibit Oncogenic RUNX1-ETO in Acute Myeloid Leukemia with Chromosome Translocation t(8;21). |
| Q36259601 | HDAC8 Inhibition Specifically Targets Inv(16) Acute Myeloid Leukemic Stem Cells by Restoring p53 Acetylation |
| Q37085891 | High expression of RUNX1 is associated with poorer outcomes in cytogenetically normal acute myeloid leukemia |
| Q89766155 | Histone deacetylase 3 preferentially binds and collaborates with the transcription factor RUNX1 to repress AML1-ETO-dependent transcription in t(8;21) AML |
| Q56984077 | Identification of Key Genes and Pathways Associated with RUNX1 Mutations in Acute Myeloid Leukemia Using Bioinformatics Analysis |
| Q35806108 | Identification of a dynamic core transcriptional network in t(8;21) AML that regulates differentiation block and self-renewal |
| Q38683676 | Immune evasion by oncogenic proteins of acute myeloid leukemia |
| Q26781526 | Interplay between Transcription Factors and the Epigenome: Insight from the Role of RUNX1 in Leukemia |
| Q36199628 | JMJD1C is required for the survival of acute myeloid leukemia by functioning as a coactivator for key transcription factors |
| Q35962533 | MiR144/451 Expression Is Repressed by RUNX1 During Megakaryopoiesis and Disturbed by RUNX1/ETO. |
| Q30252938 | Molecular Basis and Targeted Inhibition of CBFβ-SMMHC Acute Myeloid Leukemia |
| Q89777196 | Paradoxical enhancement of leukemogenesis in acute myeloid leukemia with moderately attenuated RUNX1 expressions |
| Q38255068 | Posttranslational modifications of RUNX1 as potential anticancer targets |
| Q42362636 | RUNX oncoproteins and miRNA networks |
| Q87942822 | RUNX transcription factors potentially control E-selectin expression in the bone marrow vascular niche in mice |
| Q47606063 | RUNX-mediated growth arrest and senescence are attenuated by diverse mechanisms in cells expressing RUNX1 fusion oncoproteins |
| Q92999949 | RUNX1 Dosage in Development and Cancer |
| Q51097615 | RUNX1 and CBFβ Mutations and Activities of Their Wild-Type Alleles in AML. |
| Q40329715 | RUNX1 cooperates with FLT3-ITD to induce leukemia. |
| Q52568539 | RUNX1 positively regulates the ErbB2/HER2 signaling pathway through modulating SOS1 expression in gastric cancer cells. |
| Q90162763 | RUNX1-ETO Depletion in t(8;21) AML Leads to C/EBPα- and AP-1-Mediated Alterations in Enhancer-Promoter Interaction |
| Q51097627 | RUNX1-ETO Leukemia. |
| Q33759034 | RUNX1-ETO and RUNX1-EVI1 Differentially Reprogram the Chromatin Landscape in t(8;21) and t(3;21) AML. |
| Q61815209 | RUNX1-ETO: Attacking the Epigenome for Genomic Instable Leukemia |
| Q35903884 | RUNX1B Expression Is Highly Heterogeneous and Distinguishes Megakaryocytic and Erythroid Lineage Fate in Adult Mouse Hematopoiesis |
| Q36827373 | Regain control of p53: Targeting leukemia stem cells by isoform-specific HDAC inhibition |
| Q55279547 | Regulation of RUNX1 dosage is crucial for efficient blood formation from hemogenic endothelium. |
| Q39127024 | Role of RUNX1 in hematological malignancies |
| Q50796410 | Roles of RUNX in Solid Tumors. |
| Q90526645 | Runt-related transcription factor 1 promotes apoptosis and inhibits neuroblastoma progression in vitro and in vivo |
| Q39169246 | Runx1 Orchestrates Sphingolipid Metabolism and Glucocorticoid Resistance in Lymphomagenesis. |
| Q38904253 | Runx1 Structure and Function in Blood Cell Development |
| Q35920680 | Runx1 is required for hematopoietic defects and leukemogenesis in Cbfb-MYH11 knock-in mice |
| Q38904246 | Runx3 in Immunity, Inflammation and Cancer |
| Q35043957 | Runx3-mediated transcriptional program in cytotoxic lymphocytes. |
| Q91621352 | Single-cell multiomic analysis identifies regulatory programs in mixed-phenotype acute leukemia |
| Q30276341 | Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven Cancers |
| Q37662400 | Targeting binding partners of the CBFβ-SMMHC fusion protein for the treatment of inversion 16 acute myeloid leukemia |
| Q38744455 | The Emerging Roles of RUNX Transcription Factors in Epithelial-Mesenchymal Transition |
| Q36309953 | The RUNX Genes as Conditional Oncogenes: Insights from Retroviral Targeting and Mouse Models |
| Q38319972 | The RUNX family: developmental regulators in cancer |
| Q89582296 | The RUNX1-ETO target gene RASSF2 suppresses t(8;21) AML development and regulates Rac GTPase signaling |
| Q38370113 | The RUNX1-PU.1 axis in the control of hematopoiesis. |
| Q41916378 | The miR-101/RUNX1 feedback regulatory loop modulates chemo-sensitivity and invasion in human lung cancer |
| Q38768286 | The ubiquitin ligase STUB1 regulates stability and activity of RUNX1 and RUNX1-RUNX1T1. |
| Q92337654 | Transcriptional networks in acute myeloid leukemia |
| Q91557416 | Use of polymeric CXCR4 inhibitors as siRNA delivery vehicles for the treatment of acute myeloid leukemia |
Search more.